APN/CD13 is regarded as a cancer-specific biomarker that is highly expressed on the cell membrane surface and mediates progression, invasion, and migration in various tumors, including acute myeloid leukemia, malignant pleural mesothelioma, and liver cancer13–15. Here, ANPEP is linked to acute myeloid leukemia.